Clinical Trials Logo

Clinical Trial Details — Status: Suspended

Administrative data

NCT number NCT04116281
Other study ID # 154/2019
Secondary ID
Status Suspended
Phase N/A
First received
Last updated
Start date December 2, 2019
Est. completion date February 25, 2024

Study information

Verified date July 2022
Source Universidade Federal de Sao Carlos
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Objectives: To evaluate the pressure pain threshold, shoulder biomechanics, cardiorespiratory function and the quality of life associated with the short and long-term physical therapy rehabilitation following breast cancer surgery. Methodology: The study presents three objectives and involves three groups of participants. Objective 1 is to develop a topographic map of pressure pain in the shoulder (using a digital pressure algometer), evaluate the biomechanics of the shoulder (using a digital inclinometer and load card), cardiorespiratory function (through frequency variability resting heart rate and distance traveled, through the six-minute walk test) and quality of life (through questionnaires of quality of life, anxiety, depression, sleep quality, upper limb functionality, fatigue and level of physical activity) between a group of women prior to the operation of breast cancer (experimental group, n = 36) and a group of asymptomatic controls for shoulder pain (control group, n = 18). Objective 2 is to evaluate the possible changes in the pain map over 24 weeks of supervised kinetic intervention (Supervised Physiotherapy experimental group, n = 18, will begin after drainage, frequency 3 times per week and duration of 60 minutes each session) compared to unsupervised kinetic intervention (Home Physiotherapy experimental group, n = 18, participants will receive an exercise booklet). Objective 3 is to evaluate the biomechanics of the shoulder, cardiorespiratory function and the quality of life with respect to the experimental group with and without kinesic supervision. To achieve objective 1, two baseline evaluations will be carried out in both experimental and control groups (considering the month prior to the surgery of the experimental group) and the average of the evaluations will be considered evaluation 1. To achieve objectives 2 and 3, evaluation 2 (after 4 weeks of intervention), 3 (after 12 weeks of intervention) and 4 (after 24 weeks of intervention) will be performed. The statistical analysis will include the examination of qualitative and quantitative variables. Statistical tests will be applied according to the normality of the data and a significance level of 5% will be adopted for all comparisons. Expected results: It is expected to identify sensory, biomechanical, cardiorespiratory and quality of life alterations in the experimental group, compared to the control group. In addition, after 24 weeks of intervention, the supervised experimental group will show improvement in all the aforementioned variables with respect to the unsupervised group.


Recruitment information / eligibility

Status Suspended
Enrollment 36
Est. completion date February 25, 2024
Est. primary completion date May 30, 2020
Accepts healthy volunteers No
Gender Female
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: - Surgical indication of conservative or removal breast surgery, associated with axillary lymphadenectomy or sentinel lymph node biopsy - Any type of breast cancer - Age range over 18 years Exclusion Criteria: - Breast cancer recurrence; - Surgical treatment for bilateral breast cancer; - Presence of lymphedema in the upper limb, measured by means of cirtometry of the upper limb with a measuring tape 14, asymmetries of more than 1.5 cm between the limbs were considered edema; - Diagnosis of metastases; - Shoulder pain compatible with shoulder compression symptoms as determined by the positive Hawkins-Kennedy test 30; - Previous history of surgery and fractures in the upper extremities.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Rehabilitation after breast cancer surgery
All participants are going to receive physical therapy intervention after breast cancer surgery at least removal drenaige. After that, will be randomized in two groups: Group 1 are going to receive a physical therapy program supervised by a physiotherapist; Group 2 are going to receive some instructions about the same program to perfomr at home without supervision. Both groups are going to receive 3 and 6 months of rehabilitation program.

Locations

Country Name City State
Chile Catholic University of Maule Talca Maule

Sponsors (1)

Lead Sponsor Collaborator
Universidade Federal de Sao Carlos

Country where clinical trial is conducted

Chile, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pressure pain threshold over the shoulder of breast cancer patients after a physical therapy rehabilitation program following the surgery. This outcome will involve data regarding to pressure pain threshold assessment over the shoulder at three and six monthes of treatment. Three months
Primary Pressure pain threshold over the shoulder of breast cancer patients after a physical therapy rehabilitation program following the surgery. This outcome will involve data regarding to pressure pain threshold assessment over the shoulder at three and six monthes of treatment. Six months
Primary Strength grip of breast cancer patients after a physical therapy rehabilitation program following the surgery. This outcome will involve data regarding to objective measurement that consist in to do a maximal strenth grip. The unity of measurement it is in kg. Three months
Primary Strength grip of breast cancer patients after a physical therapy rehabilitation program following the surgery. This outcome will involve data regarding to objective measurement that consist in to do a maximal strenth grip. The unity of measurement it is in kg. Six months
Secondary Upper limb functionality of breast cancer patients after a physical therapy rehabilitation program following the surgery. This outcome will involve data regarding to a questionnaire of upper limb function during activity daily routine. The questionnaire has 33 questions and each one has 5 posible answers. Three months
Secondary Upper limb functionality of breast cancer patients after a physical therapy rehabilitation program following the surgery. This outcome will involve data regarding to a questionnaire of upper limb function during activity daily routine. The questionnaire has 33 questions and each one has 5 posible answers. Six months
Secondary Fatigue of breast cancer patients after a physical therapy rehabilitation program following the surgery. This outcome will involve data regarding to a questionnaire wich contains 9 preguntas and 10 differente posibilities of answers. Three months
Secondary Fatigue of breast cancer patients after a physical therapy rehabilitation program following the surgery. This outcome will involve data regarding to a questionnaire wich contains 9 questions and 10 different posibilities of answers. Six months
Secondary Cardiopulmonary function of breast cancer patients after a physical therapy rehabilitation program following the surgery. This outcome will involve data regarding to functional capacity performed wiht the walking test measured by the distance performed after a walking. Three months
Secondary Cardiopulmonary function of breast cancer patients after a physical therapy rehabilitation program following the surgery. This outcome will involve data regarding to functional capacity performed wiht the walking test measured by the distance performed after a walking. Six months
Secondary Cardiopulmonary function of breast cancer patients after a physical therapy rehabilitation program following the surgery. This outcome will involve data regarding to heart rate variability measured with a Polar and reloj in a supine and orthostatic posture Three months
Secondary Cardiopulmonary function of breast cancer patients after a physical therapy rehabilitation program following the surgery. This outcome will involve data regarding to heart rate variability measured with a Polar and reloj in a supine and orthostatic posture Six months
Secondary Quality of life of breast cancer patients after a physical therapy rehabilitation program following the surgery. This outcome will involve data regarding to a questionnaire of quality of life regarding symptoms of chemotherapy that affects on quality of life perception. The questionnaire has 53 questions and each one has 4 posible answers. Three months
Secondary Quality of life of breast cancer patients after a physical therapy rehabilitation program following the surgery. This outcome will involve data regarding to a questionnaire of quality of life regarding symptoms of chemotherapy that affects on quality of life perception. The questionnaire has 53 questions and each one has 4 posible answers. Six months
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A